Although Th17 responses may contribute to the pathogenesis of glomerulonephritis, whether the key transcription factor in Th17 cell development, ROR␥t, also promotes glomerulonephritis is unknown. Here, we induced crescentic glomerulonephritis in wild-type and ROR␥t-deficient (ROR␥t Ϫ/Ϫ ) mice. ROR␥t Ϫ/Ϫ mice were protected from disease, with reduced histologic and functional injury and decreased leukocyte infiltration. Because ROR␥t Ϫ/Ϫ mice lack lymph nodes, which may influence the development of nephritis, we performed cell-transfer studies. We reconstituted Rag1 Ϫ/Ϫ mice, which lack adaptive immunity but otherwise have normal architecture of the lym- 
The mechanisms underlying the etiology and pathogenesis of glomerulonephritis are incompletely understood. However, previous studies have identified CD4
ϩ T helper cells as important players in proliferative forms of glomerulonephritis. 1 In particular, Th1-type infiltrating effector CD4 ϩ cells can initiate and perpetuate renal tissue damage in crescentic and necrotizing forms of glomerulonephritis. 2 After the identification of an IL-17A-secreting CD4 ϩ T cell subset (Th17), 3 it is now known that Th17 cells are involved in diseases previously thought to be Th1 mediated such as rheumatoid arthritis, 4, 5 multiple sclerosis, 6, 7 and colitis. 8 We and others have implicated Th17 responses in glomerulonephritis. Deficiency of IL-17A or of IL-23, which is important in the maintenance of Th17 responses, conferred protection from the development of experimental autoimmune glomerulonephritis, 9 anti-myeloperoxidase-directed glomerulonephritis, 10 and anti-glomerular basement mem-brane (aGBM) disease. 11 Furthermore, using cell transfer studies we have shown that antigen-specific Th17 cells alone can induce proliferative glomerulonephritis in mice. 12 However, whether the Th17 axis and especially IL-17A plays a key pathogenic role in autoinflammatory diseases remains uncertain. In contrast to earlier studies, recent work suggested that neither IL-17A deficiency nor T cell-specific overexpression of IL-17A had significant effects on experimental autoimmune encephalitis (EAE). 13 Moreover, IL-17A deficiency and antibody neutralization aggravated experimental colitis in two separate studies. 14, 15 These divergent results are potentially explained by the fact that IL-17A is not the sole cytokine produced by Th17 cells, which also produce IL-17F, IL-21, IL-22, 3, 16 and IL-9. 17 Therefore, combined neutralization of several Th17 cytokines may be needed to limit Th17 effector responses. Supporting this concept, neutralization of IL-17A and IL-17F resulted in improved outcomes in EAE 13 and limited injury in an adoptive transfer model of colitis. 18 Targeting lineage-specific transcription factors offers the opportunity to simultaneously affect multiple Th cell effector cytokines. Tbet is responsible for programming of Th1 cells, 19 GATA3 drives Th2 differentiation, 20 and the retinoid orphan receptors (RORs) ROR␣ and ROR␥t orchestrate Th17 development. [21] [22] [23] ROR␥t (more potent and better characterized than ROR␣) is crucial for Th17 effector cytokine secretion, the expression of IL-23R, the receptor for the Th17 lineageexpanding cytokine IL-23, 22, 24 and surface expression of the Th17 chemokine receptor CCR6. 23 Therefore, inhibiting ROR␥t may not only influence Th17 effector cytokines but also the Th17 subset's trafficking and expansion and has been proposed as a therapeutic target for Th17-mediated disease. 25 The potential benefits of interference with ROR␥t were demonstrated in EAE, in which absence of ROR␥t in CD4 ϩ T cells protected mice from development of encephalitis. 21 Likewise, the most potent protection in the aforementioned model of colitis (exceeding neutralization of IL-17A and IL-17F) was achieved when ROR␥t-deficient T cells were transferred. 18 To date, the functional role of ROR␥t in inflammatory renal disease is unknown. We therefore studied immune responses and glomerulonephritis in ROR␥t-deficient (ROR␥t Ϫ/Ϫ ) mice using a standard model (accelerated autologous-phase "aGBM" glomerulonephritis, in which injury is dependent on immune responses to sheep globulin localized to the GBM). Because ROR␥t Ϫ/Ϫ mice have abnormal lymph node architecture and because ROR␥t expression is not exclusively confined to Th17 cells, we performed adoptive transfer studies using different ROR␥t Ϫ/Ϫ leukocyte subsets to assess effects of leukocyte-specific and CD4 ϩ T cell-specific deficiency.
RESULTS

Glomerulonephritis is Ameliorated in ROR␥t
؊/؊ Mice Induction of accelerated autologous-phase aGBM disease in wild-type (WT) mice resulted in development of severe nephritis 10 days after injecting aGBM globulin into sensitized mice. ROR␥t Ϫ/Ϫ mice were protected from histologic and functional renal injury with fewer glomerular crescents and less necrosis, less interstitial injury ( Figure 1, A and B) , and lower albuminuria and serum urea ( Figure 1C ). Consistent with these findings, ROR␥t Ϫ/Ϫ mice demonstrated reduced numbers of glomerular CD4 ϩ T cells, macrophages, and neutrophils compared with WT mice with glomerulonephritis ( Figure 2, A and B) . Numbers of all three leukocyte populations in the renal interstitium were also reduced in ROR␥t Ϫ/Ϫ mice (Supplementary Table 1 ). Assessment of splenocyte cytokine production showed expression of IL-17A and IL-17F only in WT animals. In contrast, increased IFN␥ and IL-4 were produced by ROR␥t Ϫ/Ϫ splenocytes ( Figure 3A) . Quantification of intrarenal cytokine expression showed no measurable IL-17A mRNA in ROR␥t Ϫ/Ϫ mice, and levels of IFN␥ were similar in both strains ( Figure 3B ). Similarly, splenic mRNA expression of the Th1 transcription factor Tbet was increased in ROR␥t Ϫ/Ϫ mice, and there was a trend toward increased expression of the Th2 transcription factor GATA3, whereas renal levels were similar. Splenic expression of the Th1-associated cytokine IL-2 was similar in both groups, and although intrarenal IL-2 mRNA expression was low, it was increased in ROR␥t Ϫ/Ϫ mice (Supplementary Figure S1 ). Renal and systemic expression of mRNA for cytokines involved in Th17 differentiation is presented in Supplementary Table 2 . Analyses of humoral immune responses revealed no change in serum sheep globulin (SG)-specific IgG titers and similar production of SG-specific IgG1 and IgG2c, but IgG3 titers were enhanced in ROR␥t Ϫ/Ϫ mice ( Figure 3C ).
To ensure that ROR␥t Ϫ/Ϫ mice were not suffering from a generalized immunoparesis, additional groups of mice were immunized with SG and immune responses were analyzed after 6 days. Analysis of splenic CD4 ϩ T cell proliferation by in vivo bromodeoxyuridine (BrdU) incorporation showed higher proliferative activity in ROR␥t 26 -28 and show alterations of the splenic microenvironment. 29 Therefore, splenocytes from WT and ROR␥t Ϫ/Ϫ mice were isolated and transferred into Rag1 Ϫ/Ϫ mice. Induction of aGBM glomerulonephritis resulted in development of severe nephritis in mice that had received WT cells, with death from renal failure in most recipients within 5 days ( Figure 4A ). Rag1
Ϫ/Ϫ mice injected with ROR␥t Ϫ/Ϫ splenocytes were less affected and had improved survival, and when compared with the remaining WT splenocyte recipients they developed less histologic injury and functional impairment ( Figure 4B ). Figure 5 , A through C). In line with these findings, glomerular ( Figure 5D ) and interstitial (Supplementary Table 1 ) CD4 ϩ T cell, macrophage, and neutrophil infiltrates were decreased in ROR␥t Ϫ/Ϫ cell recipients.
Recipients of ROR␥t-Deficient CD4 ؉ T Cells Have Suppressed Th17 and Th1 Immunity SG-stimulated splenocyte IL-17A production was high in recipients of WT cells and low in the ROR␥t Ϫ/Ϫ and control groups. Production of IL-17F was below the level of detection (Ͻ15.6 pg/ml) in all groups. IFN␥ production was sup- 
pressed in the ROR␥t
Ϫ/Ϫ group, suggesting effects on Th1 responses. IL-4 levels were unchanged ( Figure 6A ). Renal cytokine mRNA expression showed no detectable IL-17A in ROR␥t-deficient cell recipients and control mice. However, intrarenal IFN␥ expression was not reduced in recipients of ROR␥t Ϫ/Ϫ cells ( Figure 6B ). Renal and systemic mRNA levels of lineage-specific transcription factors and cytokines involved in Th17 differentiation were analyzed (Supplementary Figure S2 and Supplementary Table 2 ). Flow cytometric analyses of splenocytes showed lower CD44 expression in ROR␥t Ϫ/Ϫ CD4 ϩ T cells ( Figure 6C ). Furthermore, mice. IFN␥ and IL-4 production were higher in ROR␥t Ϫ/Ϫ mice than WT mice. (B) Intrarenal IL-17A mRNA was detectable only in WT animals, whereas IFN␥ levels were similar in kidneys of both strains. (C) Serum IgG titers specific for the nephritogenic antigen (SG) were not significantly altered in ROR␥t Ϫ/Ϫ mice. Analyses of antigen-specific IgG subtypes showed no differences in IgG1 or IgG2c, whereas IgG3 production was enhanced in ROR␥t Ϫ/Ϫ mice (n ϭ 10, each group). *P Ͻ 0.05, † P Ͻ 0.001. 
Splenic CD4 ϩ T cell proliferation (BrdU incorporation) was enhanced in ROR␥t Ϫ/Ϫ mice. Similarly, CD4 T cell activation as assessed by expression of early (CD69) and late (CD44) activation markers was augmented in ROR␥t Ϫ/Ϫ mice were reconstituted with WT or ROR␥t Ϫ/Ϫ CD4 ϩ T cells, immunized with SG, and analyzed 6 days later. Flow cytometric analysis showed similar numbers of CD4 ϩ T cells in spleens of both groups. In addition, analyses of spleens and lymph nodes showed similar proportions of CD4 ϩ T cells in both groups, suggesting similar homing behavior and effective expansion of transferred cells. There were no significant differences in CD4
ϩ T cell proliferation in spleens and draining lymph nodes, but CD4 ϩ T cell activation was somewhat reduced, with lower CD44 expression in the draining lymph node. Changes in the proportion of Tregs in lymph nodes and spleens in recipients of ROR␥t-deficient T cells did not reach statistical significance at this time point (Table 2) .
ROR␥t Deficiency Ameliorates Nephritis Independently of Tregs
Given the potential for altered Treg homeostasis in the absence of ROR␥t to confound results, Treg-depleted CD4 ϩ T cell populations were prepared from splenocytes of WT and ROR␥t Ϫ/Ϫ mice (absence was confirmed by flow cytometric analyses of FoxP3 expression). Cells were transferred into Rag1 Ϫ/Ϫ mice and aGBM nephritis was induced. Although Rag1 Ϫ/Ϫ mice reconstituted with naïve WT Treg-depleted CD4 ϩ cells developed severe glomerulonephritis with prominent glomerular necrosis (one mouse died from renal failure on day 8), mice injected with Treg-depleted CD4 ϩ T cells from ROR␥t Ϫ/Ϫ mice showed less histologic and functional renal injury ( Figure 7 , A through C). Glomerular macrophage and neutrophil numbers were lower in recipients of ROR␥t Ϫ/Ϫ Treg-depleted CD4 ϩ T cells and there was a trend toward fewer glomerular CD4 ϩ T cells ( Figure 7D ), with similar findings in the interstitium (Supplementary Table 1 ). Rag1 Ϫ/Ϫ mice not reconstituted with CD4 ϩ T cells in which glomerulonephritis was induced did not show significant renal injury and only sparse leukocyte recruitment. Flow cytometric analyses of spleens from all experimental animals showed almost complete absence of FoxP3 ϩ T cells, macrophages, and neutrophils showed fewer leukocytes in the glomeruli of ROR␥t Ϫ/Ϫ cell recipients and non-cell-injected mice (n ϭ 10 WT cells, n ϭ 9 ROR␥t Ϫ/Ϫ cells, n ϭ 4 no cells). *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.0001.
Depletion of Tregs before Transfer Restores Systemic Th1 Responses and CD4
؉ T Cell Activation in Recipients of ROR␥t-Deficient Cells
To investigate the effects of ROR␥t deficiency on immune responses in the absence of any alterations in Treg homeostasis, cytokine production was assessed. As expected, splenocyte IL-17A production and intrarenal IL-17A mRNA were higher in the WT cell recipients, whereas only low levels were detected in mice injected with ROR␥t Ϫ/Ϫ cells. IL-17F was not detected. Importantly, splenocyte IFN␥ production and renal IFN␥ mRNA expression were not reduced in mice injected with ROR␥t Ϫ/Ϫ Treg-depleted CD4 ϩ cells. Splenocyte IL-4 production was not different between the three groups ( Figure 8, A  and B) , and CD4 ϩ T cell activation (CD44 expression) was similar in the ROR␥t Ϫ/Ϫ and WT group ( Figure 8C ). Renal and systemic levels of further cytokines involved in Th17 differentiation were determined and the results are presented in Supplementary Table 2 .
DISCUSSION
Several studies imply a pathogenic role for the Th17 subset in experimental inflammatory diseases, 4 -8 including glomerulonephritis, 9 -12,30 -33 with most focusing on the Th17 effector cytokine IL-17A or the Th17 lineage-expanding cytokine IL-23. However, IL-17A is secreted not only by Th17 cells but also by other cell types, including natural killer (NK) T cells, 34, 35 ␥␦ T cells, 36 noncytotoxic CD8 ϩ T cells, 37 neutrophils, 38 and mast cells. 39 The role of Th17 cell-derived IL-17A was not defined in most previous studies. IL-23, although important in Th17 responses, is produced by and also affects innate immune cells, including macrophages and neutrophils. 40, 41 Relatively few studies have investigated the effects of ROR␥t, the key transcription factor orchestrating development of Th17 cells, 3,21 on immune mediated injury. Although studies in immune disease centered on IL-17A have shown variable outcomes, [13] [14] [15] those involving deficiency of ROR␥t have so far shown only protective effects. 18, 21 Because the functional role of ROR␥t in nephritis is unknown, we studied this key Th17 transcription factor in a T cell-dependent model of aGBM disease. Past studies 18, 21 have used mice with a genetic deletion of the Rorc gene resulting in absence of ROR␥, which is expressed in multiple non-T cell tissues, as well as the thymic isoform ROR␥t, which is expressed only in leukocytes, particularly Th17 cells. The study presented here uses mice with disruption only of the Rorc(␥t) element of the Rorc gene; therefore, these mice have intact ROR␥ expression and are selectively deficient in ROR␥t. As hypothesized, our results show attenuated glomerulonephritis in mice lacking ROR␥t. Analyses of immune responses showed intrarenal IL-17A mRNA and systemic IL-17A and IL-17F production in WT mice but undetectable levels in ROR␥t Ϫ/Ϫ mice, confirming that these cytokines are ROR␥t dependent. Cellular systemic immunity in ROR␥t Ϫ/Ϫ mice was Th17 deficient with modest increases in Th1 and Th2 cytokine production and largely unaltered humoral responses (aside from the Th1-associated IgG3 subclass). There was no decrease in antigen-stimulated proliferation and activation of CD4 ϩ T cells in ROR␥t Ϫ/Ϫ mice, suggesting that deficient Th17 responses Ϫ/Ϫ cell recipients was higher (% of CD4 ϩ cells also FoxP3 ϩ ) (n ϭ 10 WT cells, n ϭ 9 ROR␥t Ϫ/Ϫ cells, n ϭ 4 no cells). *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.0001.
BASIC RESEARCH www.jasn.org
(rather than a more generalized immunoparesis) explain the attenuated disease in ROR␥t Ϫ/Ϫ mice. However, ROR␥t is not only responsible for Th17 programming but also for the development of lymphoid tissue inducer cells, a lack of which results in an absence of lymph nodes and Peyer's patches. 26 -28 Furthermore, although trafficking properties of ROR␥t Ϫ/Ϫ leukocytes are intact, their egress from spleens may be impaired because of an altered splenic microenvironment. 29 This trapping of activated leukocytes is likely to have contributed to the elevated Th1 and Th2 splenic cytokine production and increased CD4 ϩ T cell proliferation found in ROR␥t Ϫ/Ϫ mouse spleens. To bypass these possible confounders, splenocytes from naïve WT and ROR␥t Ϫ/Ϫ animals were transferred into Rag1 Ϫ/Ϫ mice, which lack T and B cells but display normal architecture of secondary lymphoid tissues. Induction of aGBM glomerulonephritis resulted in development of severe nephritis causing death from renal failure in most recipients of WT cells whereas mice that received ROR␥t Ϫ/Ϫ cells were protected.
ROR␥t is not only expressed in CD4
ϩ Th17 cells but may also be found in IL-17A-secreting ␥␦ T cells, 36 CD4
Ϫ NK T cell subsets, 34 and ROR␥t-expressing NKp46 ϩ NK-like cells. 42, 43 These cell types could contribute to our observation of reduced aGBM antibody-mediated heterologous-phase glomerular neutrophil infiltration in IL-17A Ϫ/Ϫ mice. 10 Furthermore, spleens of ROR␥ Ϫ/Ϫ mice contain lower percentages of CD4 ϩ T cells, 29 which we found also to be the case in ROR␥t Ϫ/Ϫ mice. To exclude possible effects of lower CD4 ϩ T cell numbers or differences in other ROR␥t-dependent leukocyte subsets, CD4 ϩ T cells were isolated from the spleens of both strains of mice. After transfer of equal numbers into Rag1 Ϫ/Ϫ recipients, nephritis was still attenuated in mice reconstituted with ROR␥t Ϫ/Ϫ cells. Control Rag1 Ϫ/Ϫ mice not injected with cells did not develop severe renal disease. These CD4 ϩ cell transfer studies are of additional interest because they provide further direct evidence for the central role for effector CD4 ϩ T cells in this aGBM model of glomerulonephritis, consistent with previous studies. 44, 45 Unsurprisingly, renal and systemic IL-17A was only detectable in the WT group, but systemic IFN␥ production was reduced in ROR␥t Ϫ/Ϫ mice, consistent with a recent report. 18 In addition, although CD4 ϩ cell proliferation was unaffected, activation was lower in recipients of ROR␥t-deficient cells. Because the generation of Th17 cells and Tregs is linked, 46, 47 ROR␥t deficiency could affect Treg development. Recent studies have suggested that effector T cell lineagespecific Treg subsets exist that depend on the same transcription factors as their proinflammatory counterparts. 48 -50 Therefore, ROR␥t deficiency could result in skewing of Treg subtypes and this in turn could explain the deficient T cell activation and IFN␥ cytokine secretion in the face of intact T cell proliferation. 51 Although we found no differences in the proportions of Tregs after immunizing ROR␥t Ϫ/Ϫ mice, these observations might have been influenced by the reported alterations in splenic leukocyte egress that probably leads to preferential accumulation of effector CD4 ϩ T cells. Indeed, analyses of Tregs in reconstituted Rag1 ϩ T cell numbers were also almost identical between the groups. CD4 ϩ T cell activation (CD69 expression) was similar in both groups. Expression of the activation marker CD44 was significantly lower in the LN of mice receiving ROR␥t-deficient cells. Changes in the proportion of CD4 ϩ cells that were Tregs did not reach statistical significance (n ϭ 7 WT cell recipients, n ϭ 6 ROR␥t Ϫ/Ϫ cell recipients). NA, not assessed. a P Ͻ 0.05.
is attributable neither to a defective Th1 response nor to altered Treg function, but it is highly likely to be due to impaired Th17 immunity. One recent study has suggested that a new ROR␥t-dependent Th17 subset ("natural" Th17 cells) 52 rapidly produces IL-17A in a transgenic mouse model of airway inflammation without prior antigen priming. Whether these cells comprise an independent subset of Th17 cells remains to be determined. ROR␥t-expressing NKp46 ϩ NK-like cells are not likely to be contributing to the reductions in disease observed in our transfer studies. These cells are not found in the spleen because they are selectively present in the gastrointestinal tract 42 and have therefore not been transferred. Furthermore, these cells do not produce IL-17A 42 and they are present in Rag-knockout mice, 43 which were used as recipients in our studies.
Renal injury in the absence of T cell ROR␥t was attenuated but not abrogated. This is not surprising because nephritogenic Th1 responses can also mediate glomerulonephritis. 53 In our final, most definitive study, glomerular necrosis was a prominent feature and was markedly reduced in recipients of ROR␥t
ϩ cells depleted of Tregs, suggesting an important role for the Th17 subset in elements of glomerular injury involving necrosis. Our recent study, showing that Th1 and Th17 cells can independently induce glomerular injury with a different course and pattern, underlines the importance of Th1 and Th17 nephritogenic immune responses in the development of disease. 12 In summary, the studies presented here define an important role for ROR␥t, the key Th17 transcription factor, in severe experimental glomerulonephritis. Not only global but also selective deficiency of ROR␥t in CD4 ϩ T cells ameliorates disease. These effects were not due to altered T cell activation or proliferation per se, and they were independent of Tregs. ROR␥t may therefore be a potential therapeutic target in immunologically mediated renal disease.
CONCISE METHODS
Animals, Induction of Accelerated aGBM Glomerulonephritis, and Experimental Design
ROR␥t Ϫ/Ϫ mice on the C57BL/6 background were a kind donation from Professor D. Littman (Howard Hughes Medical Institute, New York University School of Medicine, New York) 54 and were inter- cells at days 2 and 9 after the induction of nephritis to levels comparable with non-cell-injected control mice, and serum urea was lower in mice receiving ROR␥t-deficient cells. (D) ROR␥t-deficient cell recipients had a trend toward fewer CD4 ϩ cells in glomeruli, whereas macrophages and neutrophils were significantly reduced (n ϭ 9 WT cells, n ϭ 6 ROR␥t Ϫ/Ϫ cells, n ϭ 5 no cells). *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.0001. BASIC RESEARCH www.jasn.org crossed for one further generation with the C57BL/6 strain at Monash Medical Centre (Melbourne, Australia). The ROR␥t Ϫ/Ϫ genotype was confirmed by PCR analysis in each animal as described. 54 Agematched C57BL/6 WT mice were used as controls. Both strains were bred at Monash Medical Centre. Rag1 
Assessment of Renal Injury
Glomerular abnormalities were assessed on periodic acid-Schiff (PAS)-stained, Bouin-fixed, 3-m-thick, paraffin-embedded sections using coded slides. Abnormalities recorded included crescent formation, (two or more layers of cells visible in Bowman's space 55 ) and severe necrosis (Ͼ50% of the glomerular tuft affected). A minimum of 50 glomeruli was analyzed per animal to determine the percentage of crescentic and severely necrotic glomeruli. Semiquantitative analysis of tubulointerstitial damage was performed in each mouse as previously published 53 using ten randomly selected cortical areas (ϫ200). Injury was defined as tubular dilation, tubular atrophy, sloughing of tubular epithelial cells, or thickening of the basement membrane. 56 Each cortical field was scored (0 to 4) according to the amount of injury: 0, no interstitial damage; 1, Ͻ25% of the tubulointerstitium damaged; 2, 25% to 50% damaged; 3, 50% to 75% damaged; and 4, Ͼ75% of the tubulointerstitium damaged. For urine collection, mice were housed for 24 hours in metabolic cages at the time points indicated with free access to tap water, whereas serum was collected after mice were humanely culled. Albuminuria was analyzed by ELISA according to the manufacturers' instructions (Mice-Albumin Kit, Bethyl, Montgomery, TX). Serum urea was measured using standard laboratory methods at Monash Medical Centre.
To evaluate renal leukocyte infiltration, kidney sections were fixed mice receiving WT cells. Expression of IFN␥ mRNA was similar in both groups of mice that received cells, whereas only low levels were detected in the control group. (C) CD4 ϩ T cell activation was similar in WT and ROR␥t Ϫ/Ϫ mice (% of CD4 ϩ cells also CD44 hi ) (n ϭ 9 WT cells, n ϭ 6 ROR␥t Ϫ/Ϫ cells, n ϭ 5 no cells). *P Ͻ 0.05, ***P Ͻ 0.0001.
in periodate lysine paraformaldehyde for 4 hours, washed with 20% sucrose solution, and then frozen. Tissue sections were cut and a three-layer immunoperoxidase technique was used to stain for T cells, neutrophils, and macrophages. 35, 55 The primary antibodies used were GK1.5 (anti-mouse CD4; American Type Culture Collection [ATCC], Manassas, VA), RB6 -8C5 (anti-Gr-1; DNAX, Palo Alto, CA) for neutrophils, and FA/11 for macrophages (anti-mouse CD68; provided by Dr. G. Koch, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom). The secondary antibody used was rabbit anti-rat biotin (BD Biosciences, San Diego, CA). At least 25 consecutively viewed glomeruli were assessed per animal and results were expressed as cells per glomerular cross section. For assessment of interstitial leukocyte infiltration, 20 randomly selected cortical areas (ϫ400) were analyzed.
Real-Time RT-PCR Analysis
For real-time PCR analyses, 500 ng of RNA was treated with 1 unit of amplification-grade DNase I (Invitrogen, Melbourne, Australia), primed with random primers (Applied Biosystems, Foster City, CA), and reverse transcribed using a high-capacity cDNA reverse transcription kit (Applied Biosystems). Real-time PCR was performed on a Rotor Gene RG-3000 (Corbett Research, Mortlake, Australia) using FastStart DNA master Sybr Green I (Roche, Melbourne, Australia) in the case of IFN␥, IL-6, TGF␤, Tbet, GATA3, and FoxP3. For detection of IL-17A, IL-2, and IL-21, TaqMan predesigned real-time PCR assays were used (Applied Biosystems). Results are expressed as fold change relative to the housekeeping gene 18s. Primer sequences are available on request.
Systemic Cellular and Humoral Immune Responses
Spleens were removed and a single cell suspension was obtained. Splenocytes (4 ϫ 10 6 cells/ml) were cultured in RPMI/10% FCS with protein G-purified normal sheep IgG (10 g/ml) at 37°C for 72 hours. IFN␥, IL-4, IL-17A, and IL-17F concentrations were measured by ELISA as described previously. 53 The following antibodies were used: rat anti-mouse IFN␥ (R4 -6A2; BD Biosciences), biotinylated rat anti-mouse IFN␥ (XMG1.2; BD Biosciences), rat anti-mouse IL-4 (11B11; ATCC), and biotinylated rat anti-mouse IL-4 (BVD6; DNAX). For IL-17A and IL-17F, ELISA kits (DuoSet, R&D systems, Minneapolis, MN) were used. For assessment of proliferation, spleens and/or lymph nodes were obtained 6 days after immunization of experimental mice with SG in FCA. For measurements of proliferation, mice were administered an intraperitoneal injection of 1 mg of BrdU (Sigma-Aldrich, St. Louis, MO) 48, 36, 24, and 12 hours before organ harvesting. Proliferation of CD4 ϩ T cells was assessed by flow cytometric analysis of intracellular BrdU incorporation. ELISA was used to detect circulating serum SG-specific IgG titers as described previously. 57 Horseradish-peroxidase-conjugated sheep anti-mouse IgG (1:100, 1:200, and 1:800 dilutions, Amersham Biosciences, Rydalmere, Australia), horseradish-peroxidase-conjugatedconjugated goat anti-mouse IgG2c (dilution 1:200, Quantum Scientific, Murrarie, Australia [C57BL/6 mice express IgG2c instead of IgG2a]), biotinylated goat anti-mouse IgG1 (1:100, Silenius, Boronia, Australia), and rat anti-mouse IgG3 (1:10, BD Biosciences) antibodies were used. Results are expressed as OD 450 .
Isolation of Splenocyte Population for In Vivo Transfer
CD4
ϩ T cells from splenocytes were isolated by magnetic sorting (MACS, Miltenyi, Bergisch Gladbach, Germany) using the L3T4 microbead antibody (Miltenyi). by results from splenocyte cell counts (derived using a standard hemocytometer).
Statistical Analysis
Analyses were performed using the GraphPad Prism software. Differences between two groups were calculated using a t test; for three experimental groups, ANOVA analysis was performed with subsequent post hoc analysis according to Tukey. For analysis of survival, a log rank test was used. P values Ͻ0.05 were considered statistically significant.
